Search Results - Lotta Vassilev
- Showing 1 - 5 results of 5
-
1
Synergistic anti-tumor efficacy of immunogenic adenovirus ONCOS-102 (Ad5/3-D24-GM-CSF) and standard of care chemotherapy in preclinical mesothelioma model by Łukasz Kuryk, Elina Haavisto, Mariangela Garofalo, Cristian Capasso, Mari Hirvinen, Sari Pesonen, Tuuli Ranki, Lotta Vassilev, Vincenzo Cerullo
Published 2016Artigo -
2
Oncolytic adenovirus and doxorubicin‐based chemotherapy results in synergistic antitumor activity against soft‐tissue sarcoma by Mikko Siurala, Simona Bramante, Lotta Vassilev, Mari Hirvinen, Suvi Parviainen, Siri Tähtinen, Kilian Guse, Vincenzo Cerullo, Anna Kanerva, Anja Kipar, Markus Vähä‐Koskela, Akseli Hemminki
Published 2014Artigo -
3
Repeated intratumoral administration of ONCOS-102 leads to systemic antitumor CD8<sup>+</sup>T-cell response and robust cellular and transcriptional immune activation at tumor site... by Lotta Vassilev, Tuuli Ranki, Timo Joensuu, Elke Jäger, Julia Karbach, Claudia Wahle, Kaarina Partanen, Kalevi Kairemo, Tuomo Alanko, Riku Turkki, Nina Linder, Johan Lundin, Ari Ristimäki, Matti Kankainen, Akseli Hemminki, Charlotta Backman, Kasper Dienel, Mia von Euler, Elina Haavisto, Tiina Hakonen, Juuso Juhila, Magnus Jäderberg, Petri Priha, Antti Vuolanto, Sari Pesonen
Published 2015Artigo -
4
Local treatment of a pleural mesothelioma tumor with ONCOS-102 induces a systemic antitumor CD8<sup>+</sup>T-cell response, prominent infiltration of CD8<sup>+</sup>lymphocytes and... by Tuuli Ranki, Timo Joensuu, Elke Jäger, Julia Karbach, Claudia Wahle, Kalevi Kairemo, Tuomo Alanko, Kaarina Partanen, Riku Turkki, Nina Linder, Johan Lundin, Ari Ristimäki, Matti Kankainen, Akseli Hemminki, Charlotta Backman, Kasper Dienel, Mikael von Euler, Elina Haavisto, Tiina Hakonen, Juuso Juhila, Magnus Jäderberg, Petri Priha, Lotta Vassilev, Antti Vuolanto, Sari Pesonen
Published 2014Artigo -
5
Phase I study with ONCOS-102 for the treatment of solid tumors – an evaluation of clinical response and exploratory analyses of immune markers by Tuuli Ranki, Sari Pesonen, Akseli Hemminki, Kaarina Partanen, Kalevi Kairemo, Tuomo Alanko, Johan Lundin, Nina Linder, Riku Turkki, Ari Ristimäki, Elke Jäger, Julia Karbach, Claudia Wahle, Matti Kankainen, Charlotta Backman, Mikael von Euler, Elina Haavisto, Tiina Hakonen, Raita Heiskanen, Magnus Jäderberg, Juuso Juhila, Petri Priha, Laura Suoranta, Lotta Vassilev, Antti Vuolanto, Timo Joensuu
Published 2016Artigo
Search Tools:
Related Subjects
Medicine
Cancer research
Internal medicine
Oncolytic virus
Biology
CD8
Chemotherapy
Immune system
Immunology
Antigen
Biochemistry
Cancer
Immunotherapy
In vitro
Oncology
Oncolytic adenovirus
Pathology
Adverse effect
Biotechnology
Carboplatin
Cell culture
Chemistry
Cisplatin
Clinical endpoint
Clinical trial
Cyclophosphamide
Cytotoxic T cell
Doxorubicin
ELISPOT
Etoposide